TriSalus Life Sciences (TLSI) Common Equity (2020 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Common Equity of $12.8 million for Q1 2026, up 137.26% year-over-year from $5.4 million in Q1 2025, and up 137.82% quarter-over-quarter from -$33.9 million in Q4 2025.
TriSalus Life Sciences (TLSI) Common Equity (2020 - 2026) Analysis & Trends
TriSalus Life Sciences' Common Equity history runs 7 years deep, the most recent figure standing at $12.8 million for Q1 2026.
- In Q1 2026, Common Equity rose 137.26% year-over-year to $12.8 million; the TTM figure through Mar 2026 stood at $12.8 million (up 137.26% YoY), while the FY2025 annual figure was -$33.9 million, down 30.77% from the prior year.
- Common Equity for Q1 2026 stood at $12.8 million, up from -$33.9 million in the prior quarter.
- The five-year high for Common Equity was $12.8 million in Q1 2026, with the low at -$198.4 million in Q2 2023.
- The 5-year median for Common Equity is -$33.9 million (2025), against an average of -$72.1 million.
- The sharpest annual moves came in 2022 and 2026: Common Equity tumbled 684.82% in 2022, then jumped 137.26% in 2026.
- TriSalus Life Sciences' Common Equity stood at -$177.1 million in 2022, then surged by 84.72% to -$27.1 million in 2023, then grew by 4.33% to -$25.9 million in 2024, then sank by 30.77% to -$33.9 million in 2025, then soared by 137.82% to $12.8 million in 2026.
- Business Quant data shows TLSI's Common Equity at $12.8 million in Q1 2026, -$33.9 million in Q4 2025, and -$26.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 7.22 Bn |
| 10 | TriSalus Life Sciences | 304.89 Mn | 258.60 Mn | 9.90 Mn | 6.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.55 Mn |
| Mar 31, 2026 | 12.81 Mn |
| Dec 31, 2025 | -33.86 Mn |
| Sep 30, 2025 | -26.73 Mn |
| Jun 30, 2025 | -19.42 Mn |
| Mar 31, 2025 | -34.37 Mn |
| Dec 31, 2024 | -25.89 Mn |
| Sep 30, 2024 | -20.43 Mn |
| Jun 30, 2024 | -25.26 Mn |
| Mar 31, 2024 | -36.04 Mn |
| Dec 31, 2023 | -27.07 Mn |
| Sep 30, 2023 | 8.29 Mn |
| Jun 30, 2023 | -198.42 Mn |
| Mar 31, 2023 | -184.52 Mn |
| Dec 31, 2022 | -177.13 Mn |
| Sep 30, 2022 | -153.93 Mn |
| Jun 30, 2022 | -145.96 Mn |
| Mar 31, 2022 | -137.35 Mn |
| Dec 31, 2021 | -129.61 Mn |
| Sep 30, 2021 | -19.61 Mn |